223 related articles for article (PubMed ID: 34879171)
1. Chemically Synthesized, Self-Assembling Small Interfering RNA-Prohead RNA Molecules Trigger Dicer-Independent Gene Silencing.
Hill AC; van Leeuwen D; Schlösser V; Behera A; Mateescu B; Hall J
Chemistry; 2022 Feb; 28(8):e202103995. PubMed ID: 34879171
[TBL] [Abstract][Full Text] [Related]
2. Thermodynamic stabilities of three-way junction nanomotifs in prohead RNA.
Hill AC; Schroeder SJ
RNA; 2017 Apr; 23(4):521-529. PubMed ID: 28069889
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Dicer Knockout on RNA Interference Using Various Dicer Substrate Small Interfering RNA (DsiRNA) Structures.
Song MS; Alluin J; Rossi JJ
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327991
[TBL] [Abstract][Full Text] [Related]
4. Deep Sequencing Analyses of DsiRNAs Reveal the Influence of 3' Terminal Overhangs on Dicing Polarity, Strand Selectivity, and RNA Editing of siRNAs.
Zhou J; Song MS; Jacobi AM; Behlke MA; Wu X; Rossi JJ
Mol Ther Nucleic Acids; 2012 Apr; 1(4):e17. PubMed ID: 23343928
[TBL] [Abstract][Full Text] [Related]
5. Assessment and comparison of thermal stability of phosphorothioate-DNA, DNA, RNA, 2'-F RNA, and LNA in the context of Phi29 pRNA 3WJ.
Piao X; Wang H; Binzel DW; Guo P
RNA; 2018 Jan; 24(1):67-76. PubMed ID: 29051199
[TBL] [Abstract][Full Text] [Related]
6. Assembly of therapeutic pRNA-siRNA nanoparticles using bipartite approach.
Shu Y; Cinier M; Fox SR; Ben-Johnathan N; Guo P
Mol Ther; 2011 Jul; 19(7):1304-11. PubMed ID: 21468002
[TBL] [Abstract][Full Text] [Related]
7. Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition.
Zhou J; Shu Y; Guo P; Smith DD; Rossi JJ
Methods; 2011 Jun; 54(2):284-94. PubMed ID: 21256218
[TBL] [Abstract][Full Text] [Related]
8. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.
Lee TJ; Haque F; Shu D; Yoo JY; Li H; Yokel RA; Horbinski C; Kim TH; Kim SH; Kwon CH; Nakano I; Kaur B; Guo P; Croce CM
Oncotarget; 2015 Jun; 6(17):14766-76. PubMed ID: 25885522
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis for improved gene silencing by Dicer substrate interfering RNA compared with other siRNA variants.
Snead NM; Wu X; Li A; Cui Q; Sakurai K; Burnett JC; Rossi JJ
Nucleic Acids Res; 2013 Jul; 41(12):6209-21. PubMed ID: 23620279
[TBL] [Abstract][Full Text] [Related]
10. Utilizing RNA nanotechnology to construct negatively charged and ultrasound-responsive nanodroplets for targeted delivery of siRNA.
Guo L; Shi D; Shang M; Sun X; Meng D; Liu X; Zhou X; Li J
Drug Deliv; 2022 Dec; 29(1):316-327. PubMed ID: 35037525
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi.
Ohnishi Y; Tamura Y; Yoshida M; Tokunaga K; Hohjoh H
PLoS One; 2008 May; 3(5):e2248. PubMed ID: 18493311
[TBL] [Abstract][Full Text] [Related]
12. Bioengineered Bacteriophage-Like Nanoparticles as RNAi Therapeutics to Enhance Radiotherapy against Glioblastomas.
Pang HH; Huang CY; Chen PY; Li NS; Hsu YP; Wu JK; Fan HF; Wei KC; Yang HW
ACS Nano; 2023 Jun; 17(11):10407-10422. PubMed ID: 37120837
[TBL] [Abstract][Full Text] [Related]
13. Rational design for controlled release of Dicer-substrate siRNA harbored in phi29 pRNA-based nanoparticles.
Binzel DW; Guo S; Yin H; Lee TJ; Liu S; Shu D; Guo P
Mol Ther Nucleic Acids; 2021 Sep; 25():524-535. PubMed ID: 34589275
[TBL] [Abstract][Full Text] [Related]
14. The C-terminal dsRNA-binding domain of
Kandasamy SK; Zhu L; Fukunaga R
RNA; 2017 Jul; 23(7):1139-1153. PubMed ID: 28416567
[No Abstract] [Full Text] [Related]
15. The design, preparation, and evaluation of asymmetric small interfering RNA for specific gene silencing in mammalian cells.
Chang C; Hong SW; Dua P; Kim S; Lee DK
Methods Mol Biol; 2013; 942():135-52. PubMed ID: 23027049
[TBL] [Abstract][Full Text] [Related]
16. Enzymatically produced pools of canonical and Dicer-substrate siRNA molecules display comparable gene silencing and antiviral activities against herpes simplex virus.
Romanovskaya A; Paavilainen H; Nygårdas M; Bamford DH; Hukkanen V; Poranen MM
PLoS One; 2012; 7(11):e51019. PubMed ID: 23226452
[TBL] [Abstract][Full Text] [Related]
17. Gene silencing mediated by small interfering RNAs in mammalian cells.
Scherr M; Morgan MA; Eder M
Curr Med Chem; 2003 Feb; 10(3):245-56. PubMed ID: 12570711
[TBL] [Abstract][Full Text] [Related]
18. Increased potency and longevity of gene silencing using validated Dicer substrates.
Hefner E; Clark K; Whitman C; Behlke MA; Rose SD; Peek AS; Rubio T
J Biomol Tech; 2008 Sep; 19(4):231-7. PubMed ID: 19137112
[TBL] [Abstract][Full Text] [Related]
19. Rational design and in vitro and in vivo delivery of Dicer substrate siRNA.
Amarzguioui M; Lundberg P; Cantin E; Hagstrom J; Behlke MA; Rossi JJ
Nat Protoc; 2006; 1(2):508-17. PubMed ID: 17406276
[TBL] [Abstract][Full Text] [Related]
20. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
